Caruso M L, Valentini A M
Department of Pathology, Scientific Institute of Gastroenterology, Castellana Grotte, BA, Italy.
Anticancer Res. 1997 Nov-Dec;17(6D):4671-5.
The p53 tumour suppressor protein can be ineffective because of mutations in the p53 gene or interactions with proteins synthesized by specific subtypes of HPV. We investigated the localization of p53 protein in association with HPV in paraffin sections of 10 dysplastic and 12 malignant laryngeal squamous epithelium specimens by using immunohistochemical and in situ hybridization techniques. Viral HPV type 16 or 18 related sequences were identified only in a squamous cell carcinoma (SCC) specimen. p53 was detected in 64% of cases studied. All p53+ specimens showed no HPVrelated sequences; the only HPV+ case was p53 negative. In our study, the increased p53 expression in the process from dysplastic to invasive SCC indicates that p53 overexpression is an early event in laryngeal carcinogenesis. Moreover, the systemic susceptibility to HPV infection suggests the need for an accurate evaluation of SCC risk not only in the genital tract in female patients shown to be positive for transforming HPV types (16 or 18).
由于p53基因的突变或与特定HPV亚型合成的蛋白质的相互作用,p53肿瘤抑制蛋白可能会失效。我们使用免疫组织化学和原位杂交技术,研究了10例发育异常和12例恶性喉鳞状上皮标本石蜡切片中p53蛋白与HPV的定位关系。仅在1例鳞状细胞癌(SCC)标本中鉴定出16型或18型HPV相关序列。在所研究的病例中,64%检测到p53。所有p53阳性标本均未显示HPV相关序列;唯一的HPV阳性病例p53为阴性。在我们的研究中,从发育异常到浸润性SCC过程中p53表达增加表明,p53过表达是喉癌发生的早期事件。此外,对HPV感染的全身易感性表明,不仅对于被证明感染转化型HPV(16或18型)呈阳性的女性患者的生殖道SCC风险,而且对于其他情况,都需要进行准确评估。